Hypotron

Midodrine, the active ingredient in Hypotron, is a Alpha-1 adrenergic agonist presented as an oral tablet for oral use. It is indicated for the treatment of orthostatic hypotension in adults who experience a drop in blood pressure upon standing.

GNH USA supplies Hypotron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Midodrine acts on the vascular adrenergic system to raise standing blood pressure, making it useful for conditions characterized by orthostatic drops.

- Orthostatic hypotension: increases systolic pressure on standing and reduces dizziness. - Neurogenic orthostatic hypotension: improves autonomic regulation of vascular tone. - Post‑ural hypotension: helps maintain cerebral perfusion after sitting or lying down.

Midodrine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Piloerection: localized goose‑flesh. - Pruritus: itching of the skin. - Urinary urgency: increased frequency of urination. - Supine hypertension: elevated blood pressure when lying down. - Nausea: mild stomach upset. - Headache: tension‑type discomfort.

Serious or Rare Side Effects: - Severe hypertension: risk of hypertensive crisis. - Cardiac arrhythmias: irregular heart rhythms. - Ischemic events: chest pain or peripheral ischemia. - Allergic reactions: rash, swelling, or anaphylaxis. - Renal impairment: worsening kidney function in susceptible patients.

Before initiating therapy, clinicians should evaluate patient history and monitor for specific risks.

- Blood pressure monitoring: check supine and standing pressures regularly. - Cardiovascular disease: use cautiously in patients with heart failure or coronary artery disease. - Renal function: adjust use if severe renal impairment is present. - Concomitant antihypertensives: avoid additive blood‑pressure lowering effects. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture.

Midodrine can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Sympathomimetic agents: additive pressor effects may cause severe hypertension.

Moderate Interactions (Monitor Closely): - Diuretics: may amplify orthostatic blood‑pressure changes. - Anticholinergic drugs: can increase urinary retention risk. - Beta‑blockers: may blunt compensatory heart‑rate response.